UAlberta study reveals sex-based differences in outcomes for atrial fibrillation

Yet more evidence can be added to the growing literature that shows women with cardiovascular disease may receive different health care and experience worse outcomes than men.

A study analyzing data from 21,062 Albertans discharged from hospital emergency rooms after presenting primarily for atrial fibrillation/flutter (AFF) showed that 1.3 per cent of women and 0.9 per cent of men died up to one month later. That translates to 40 per cent more women than men.

"We found this to be true after adjusting for factors such as age and other health-related variables," said Rhonda Rosychuk, a statistician and professor in Pediatrics at the U of A. "It's an unexpected discrepancy."

The study also showed that women experienced shorter or longer wait times to see a physician and specialist in follow-up care depending on other factors.

It's far too early to draw any causal connections with the higher death rates, explained Rosychuk.

"Further examination is required to determine if these differences are systemic, for example, related to care delivery."

But there's no denying the consequence of these findings given the mortality and time to death varied based on sex, she added.

"Overall, emergency, family medicine and specialist clinician groups should be aware of these differences and do their best to ensure evidence-based management is provided to both men and women."

This is the first study to establish sex-based difference in outcomes after discharged from Alberta emergency departments after AFF presentation. Previous investigators have identified numerous sex-based differences in AFF.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers discover new target for treating atherosclerosis